NIH-funded research NIH-funded research

Exploring antiviral systems in microbial eukaryotes like amoebas

Official title: Antiviral Discovery in Microbial Eukaryotes

Funded at University of Washington · NIH-10947358 · Data updated 2026-11-12

This study looks at how tiny organisms called amoebas fight off viruses, hoping to discover new ways to use their defenses to improve medicine and technology for everyone.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 14, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$477,226
NIH project number1DP2AI184554-01
Project IDNIH-10947358 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from autoimmune diseases or viral infections that may benefit from novel antiviral strategies.

Less likely to help

Patients with conditions unrelated to viral infections or autoimmune responses may not receive any benefit from this research.

What this research studies

This research investigates how microbial eukaryotes, particularly amoebas, defend against viral infections. By examining the antiviral systems these organisms use, the project aims to uncover new mechanisms that could lead to advancements in biotechnology and medicine. The approach involves identifying and characterizing the unique antiviral responses of these eukaryotes, which are less understood compared to those in humans and other organisms. This could provide insights into how these systems can be harnessed for therapeutic purposes.

Why it matters

Potential benefit: If successful, this research could lead to new antiviral therapies that improve treatment options for viral infections and autoimmune diseases.

How similar studies have gone: While research on antiviral systems in prokaryotes has shown success, the exploration of these systems in microbial eukaryotes is relatively novel and untested.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Jordan, Tristan Xavier — University of Washington
  • Study coordinator: Jordan, Tristan Xavier

Related research

Other NIH-funded projects on the same topics.

  • Making genetic testing more accessible to the public

    This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.

    NIH research University of Washington · Seattle, United States · NIH-9845571

  • Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana

    A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.

    NIH research University of Washington · Seattle, United States · NIH-11645064

  • Binaural Hearing and Speech in Noise in Children

    This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.

    NIH research University of Washington · Seattle, United States · NIH-11631484

  • Neural circuits that control pain aversion in the brain

    Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.

    NIH research University of Washington · Seattle, United States · NIH-11629742

  • United World Antiviral Research Network (UWARN)

    A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.

    NIH research University of Washington · Seattle, United States · NIH-11627864

  • HF endotypes in heart failure using ethical multi-modal AI and molecular data

    A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.

    NIH research University of Washington · Seattle, United States · NIH-11621806

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.